Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications use oral corticosteroids risk acute myocardial infarction
Discrete Choice Experiments and Conjoint Analysis As a pharmaceutical or device manufacturer, your products have different attributes related to safety, efficacy, mode of administration, etc. and so do your competitor’s products—but, do you know which of …
… Mary Anthony Pharmacoepidemiology and Risk Management Women's Health Rheumatology Diabetes & … at RTI-HS, she has focused on pharmacoepidemiology and risk management projects and works as an epidemiology … The focus of recent projects that she has led include the use of databases to address regulatory agency-required …
… same answer. Q: What happens if authors don't use the CHEERS 2022 guidance? A: I don't know for sure. I …
… of therapeutic areas, including oncology, chronic and acute respiratory conditions, renal diseases, dermatology, …
Oncology A Wealth of Experience We have collaborated with our clients on projects to research cancer, cancer treatment, and complications and comorbidities of cancer. Our experience includes: Basal cell carcinoma Bladder cancer Breast cancer Cervical …
… multiple conferences, leading to several poster and oral presentation awards. …
ISPOR Europe 2022 Vienna Share on: Sunday, November 6 - Wednesday, November 9, 2022 Conference Website Image If you are looking for ISPOREU 2023, click here. We're looking forward to seeing you live and in person at ISPOR in Vienna! We invite you to stop …
How are United States ICER'S Evidence Ratings Determined? You can read the related research here: How are United States ICER'S evidence ratings determined?: A systematic review of ICER'S evidence ratings in evidence reports for new drugs in 2020 and 2021. …
… Overall survival Adverse events Healthcare resource use and costs Study results highlighted the following …
RTI-HS Webinar - Lessons Learned From a Review of FDA PRO Labeling Share on: December 12, 2016 Image Click to view this webinar - Lessons Learned from a Review of FDA PRO Labeling The last decade has seen an increased focus on patient-centered drug …